Skip to content
CMS listens to BIO and understands proposed policies could have harmed patients, innovation
A new suite of rules governing drug rebates in Medicaid has been finalized, removing months of uncertainty about whether the Centers for Medicare and […]
Latest News
Sepsis Awareness Month: 3 things you need to know about sepsis
September is Sepsis Awareness Month, and the Biotechnology Innovation Organization (BIO) is partnering with Sepsis Alliance to spread the word about sepsis and provide
Sepsis Awareness Month: 3 things you need to know about sepsis Read More »
I am BIO Podcast: Biotechnology is national security technology
American leadership in biotechnology is a vital national security asset in need of protection now, and its importance can be expected to grow in
I am BIO Podcast: Biotechnology is national security technology Read More »
BIO and BBC StoryWorks call for biotech stories
Since 2019, the Biotechnology Innovation Organization (BIO) has worked with BBC StoryWorks Commercial Productions, the BBC’s award-winning branded content division, to bring stories of
BIO and BBC StoryWorks call for biotech stories Read More »
Capitol Hill update: House advances PPRV reauthorization, Senate reviews IRA
During a busy week in Congress, House legislation to support drug development for pediatric rare diseases moved forward with bipartisan support, and a Senate
Capitol Hill update: House advances PPRV reauthorization, Senate reviews IRA Read More »
Virginia Gov. Youngkin named BIO’s Governor of the Year
Virginia Gov. Glenn Youngkin on Sept. 17 received the 2024 Governor of the Year Award from the Biotechnology Innovation Organization (BIO) in recognition of
Virginia Gov. Youngkin named BIO’s Governor of the Year Read More »
BIO’s John Torres on his appointment to the ATAC and the future of agricultural trade
John Torres, Senior Director, Federal Government Relations – Agriculture and Environment at the Biotechnology Innovation Organization (BIO), was recently appointed to the U.S. Department
BIO’s John Torres on his appointment to the ATAC and the future of agricultural trade Read More »
BIO’s view: Sanders’ latest attack on innovation misses realities about groundbreaking drugs
Yesterday, Sen. Bernie Sanders held a meeting about the new class of groundbreaking diabetes and weight-loss medicines. Next week, he will hold a hearing
Four key facts ahead of tomorrow’s drug pricing hearing
The Senate Finance Committee will hold a hearing tomorrow on “understanding the benefits of the Inflation Reduction Act.” Expect to hear a lot of rhetoric
Four key facts ahead of tomorrow’s drug pricing hearing Read More »
House members seek to block new wildlife refuge rules regarding GE crops
Members of Congress discussed legislation to block proposed federal rules that would regulate growth of genetically engineered crops on wildlife refuges during a Sept.
House members seek to block new wildlife refuge rules regarding GE crops Read More »